TherapeuticsMD, Inc. (TXMD) Gross profit 2016–2023
TherapeuticsMD, Inc. (TXMD) annual gross profit history from SEC filings — each fiscal year as reported.
$1.3MFY2023 · since FY2016: $15.2M → $1.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | $1.3M | -98.1% |
| FY2022 | $68.6M | +5755.3% |
| FY2021 | $1.2M | -97.6% |
| FY2020 | $48.9M | +12.9% |
| FY2019 | $43.3M | +224.1% |
| FY2018 | $13.4M | -5.5% |
| FY2017 | $14.1M | -6.8% |
| FY2016 | $15.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More TXMD financial trends
TXMD RevenueTXMD Net incomeTXMD Net marginTXMD Gross marginTXMD Operating incomeTXMD Operating marginTXMD Operating cash flowTXMD Free cash flowTXMD Capital expendituresTXMD Return on equityTXMD Stock buybacksTXMD Dividends paidTXMD Total assetsTXMD Total liabilitiesTXMD Shareholders’ equityTXMD overview →